Development and Evaluation of Insulin Incorporated Nanoparticles for Oral Administration

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="10"><hr/></td></tr><tr class="thead"><td align="left">Buffers</td><td align="center" colspan="4">HCL buffer pH = 1.2</td><td align="center" colspan="5">Phosphate buffer pH = 6.8</td></tr><tr><td class="thead-hr" colspan="10"><hr/></td></tr><tr><td align="left">Time (min)</td><td align="center">015</td><td align="center">030</td><td align="center">060</td><td align="center">120</td><td align="center">135</td><td align="center">150</td><td align="center">180</td><td align="center">240</td><td align="center">300</td></tr><tr><td align="left">Mean % cumulative release ± SD</td><td align="center">37.91 ± 0.71</td><td align="center">46.48 ± 1.06</td><td align="center">49.09 ± 0.75</td><td align="center">50.78 ± 0.76</td><td align="center">57.09 ± 0.26</td><td align="center">62.35 ± 2.04</td><td align="center">64.10 ± 1.12</td><td align="center">65.42 ± 0.35</td><td align="center">66.06 ± 0.09</td></tr><tr class="table-tr"><td colspan="10"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Percentage cumulative release study of insulin loaded nanoparticles in different buffer systems.

International Scholarly Research Notices

tab3

Table 3

Table 3: Development and Evaluation of Insulin Incorporated Nanoparticles for Oral Administration 